Botanical species · safety record

Linaria vulgaris

The EFSA Compendium of Botanicals holds 6 constituent measurements for Linaria vulgaris. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Linaria vulgaris Mill.

6Constituent measurements
0Safety records
3Cited sources
5Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 5 licensed products naming Linaria vulgaris as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Whole plant
  • Whole plant(s)

What the records describe

Constituents measured

  • Liriodendrin2
  • Quinazoline alkaloids2
  • Benzaldehyde1
  • Pyridine alkaloids1

Plant parts

  • Aerial part of plants4
  • Live plants2

Preparations

  • Solvent extraction3

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
LiriodendrinAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Quinazoline alkaloidsAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Quinazoline alkaloidsAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
BenzaldehydeLive plantsGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier
LiriodendrinLive plantsGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier
Pyridine alkaloidsAerial part of plantsNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Hua, H.-M., Li, X., Xing, S.-E., Pei, Y.-H. Study on the chemical constituents of Linaria vulgaris. Chinese pharmaceutical journal, 2005, vol. 40, no. 9, p. 653-656.
  2. Hua, HM., Cheng, MS., Li, X., Pei, YH. A new pyrroloquinazoline alkaloid from Linaria vulgaris. Chemical & pharmaceutical bulletin, 2002, vol. 50, no. 10, p. 1393-1394. DOI
  3. Hua, Huiming., Piao, Fenghua., Wang, Suxian., Li, Xian., Qiao, Bolu., Li, Ping. Study on a new alkaloid of Linaria vulgaris. Shenyang yaoke daxue xuebao, 1997, vol. 14, no. 3, p. 219-220.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue